The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Prilocard 2.5 mg tablets for dogs

2.5 mg/tablet Tablet

aniMedica GmbH VPA10826/015/002

Main Information

Trade NamePrilocard 2.5 mg tablets for dogs
Active SubstancesRamipril
Strength2.5 mg/tablet
Dosage FormTablet
Licence HolderaniMedica GmbH
Licence NumberVPA10826/015/002

Group Information

ATC CodeQC09AA05 ramipril
Therapeutic ClassCardiovascular


Withdrawn Date01/12/2019
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back